Veille Scientifique

La veille scientifique est un nouveau service proposé par la SNFGE. Elle se veut un recensement rapide et assez exhaustif des articles publiés dans les revues majeures (New England Journal of Medicine, Lancet, JAMA, Gastroenterology, Gut, Lancet Oncology, Journal of Clinical Oncology, Hepatology, Journal of Hepatology, Endoscopy, Gastrointestinal Endoscopy...).
 

Patrice PIENKOWSKI
 Coordinateur

Six groupes animés par un responsable se chargent de ce travail tous les mois :

Cancers Endoscopie Foie/
VB
Gastro/
Procto/

Nutrition
MICI Pancréas
R. FAROUX E. CORON C. SILVAIN P. JOUET S. NAHON V. REBOURS
T. APARICIO
B. DENIS
S. MANFREDI
Y. TOUCHEFEU
D. TOUGERON

C. CELLIER
E. CHABRUN
F. ROSTAIN
JM. ROUILLON

B. HANSLIK
JL. PAYEN
JM. PERON
D. VALLA

H. DAMON
P. DUCROTTE
F. CORDET
V. COSTIL
P. COULOM
V. de PARADES
F. ZERBIB

V. ABITBOL
P. FAURE
P. MARTEAU
B. PARIENTE
P. SEKSIK
M. CAMUS
P. DELASALLE
L. de MESTIER


Nous espérons de ce nouvel outil qu’il vous aide à accéder rapidement et sélectivement aux données nouvelles de notre discipline selon vos sujets d’intérêt, qu’ils soient larges ou très spécifiques.

Revue Titre Date Coup de coeur Thématique
Inflammatory Bowel Diseases Capsule Endoscopy: Diagnostic Accuracy of Lewis Score in Patients with Suspected Crohn's Disease oct. 15 2 ♥ MICI
Hepatology Randomized phase 3 trial of ombitasvir/paritaprevir/ritonavir for hepatitis C virus genotype 1b-infected Japanese patients with or without cirrhosis oct. 15 2 ♥ Foie, Hépatites virales
Hepatology World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma oct. 15 1 ♥ Foie, Hépatites virales, Carcinome hépatocellulaire (CHC)
Hepatology Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infection oct. 15 2 ♥ Foie, Hépatites virales
Hepatology Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 in patients with cirrhosis oct. 15 2 ♥ Foie, Hépatites virales
Hepatology Reproducibility of mRECIST in assessing response to transarterial radioembolization therapy in hepatocellular carcinoma oct. 15 3 ♥ Foie, Carcinome hépatocellulaire (CHC)
Hepatology The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease oct. 15 3 ♥ Foie
Hepatology Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy oct. 15 4 ♥ Foie
Inflammatory Bowel Diseases Silent Crohn's Disease: Asymptomatic Patients with Elevated C-reactive Protein Are at Risk for Subsequent Hospitalization oct. 15 2 ♥ MICI
Gut Faecal haemoglobin concentration influences risk prediction of interval cancers resulting from inadequate colonoscopy quality: analysis of the Taiwanese Nationwide Colorectal Cancer Screening Program oct. 15 3 ♥ Cancer colorectal (CCR), Endoscopie/Imagerie
Gastroenterology Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn’s Disease oct. 15 3 ♥ MICI
Clinical Infectious Diseases High Proportion of Asymptomatic Infections in an Outbreak of Hepatitis E Associated With a Spit-Roasted Piglet, France, 2013 oct. 15 5 ♥ Foie, Hépatites virales
Gastroenterology Combination of Tenofovir Disoproxil Fumarate and Peginterferon alfa-2a Increases Loss of Hepatitis B Surface Antigen in Patients with Chronic Hepatitis B oct. 15 3 ♥ Foie, Hépatites virales
The Lancet Oncology Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial oct. 15 1 ♥ Cancer colorectal (CCR)
The Lancet Oncology Bevacizumab with or without erlotinib as maintenance therapy in patients with metastatic colorectal cancer (GERCOR DREAM; OPTIMOX3): a randomised, open-label, phase 3 trial oct. 15 2 ♥ Cancer colorectal (CCR)
Gut Impact of common risk factors of fibrosis progression in chronic hepatitis C oct. 15 4 ♥ Foie, Hépatites virales
The Lancet Oncology FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study oct. 15 3 ♥ Cancer colorectal (CCR)
Gut Acute kidney injury and acute-on-chronic liver failure classifications in prognosis assessment of patients with acute decompensation of cirrhosis oct. 15 3 ♥ Foie
Journal of Hepatology Increased incidence of cancer and cancer-related mortality among persons with chronic hepatitis C infection, 2006–2010 oct. 15 4 ♥ Foie, Hépatites virales, Cancers autres
Gastroenterology Effectiveness of Simeprevir plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients with HCV Genotype 1 Infection oct. 15 2 ♥ Foie, Hépatites virales
Journal of Hepatology EASL Clinical Practice Guidelines: Autoimmune hepatitis oct. 15 5 ♥ Foie, Hépatites virales
Journal of Hepatology Pharmacokinetics and safety of co-administered paritaprevir plus ritonavir, ombitasvir, and dasabuvir in hepatic impairment oct. 15 3 ♥ Foie, Hépatites virales
Gastroenterology Statins are Associated with a Decreased Risk of Decompensation and Death in Veterans with Hepatitis C-related Compensated Cirrhosis oct. 15 4 ♥ Foie
Gut MRI with hyperpolarised [1-13C]pyruvate detects advanced pancreatic preneoplasia prior to invasive disease in a mouse model sep. 15 3 ♥ Cancers autres (hors CCR et CHC), Pancréas/Voies biliaires
Endoscopy Endoscopic ultrasound-guided biliary drainage after failed ERCP: cumulative experience of 101 procedures at a single center sep. 15 3 ♥ Endoscopie/Imagerie

Pages